HER2 Assessment in Breast Cancer

What is HER2 Testing in Breast Cancer? | Dr Kiley LohПодробнее

Understanding and Assessing HR+ HER2- Metastatic Breast Cancer w/Dr. Shaina A. RozellПодробнее

HER2-Targeted Strategies for HER2-Positive Gastro and Colorectal Cancers — John Strickler, MDПодробнее

What are the various types of HER2 testing?Подробнее

Assessment and Followup for Early Stage HR+ HER2- Metastatic Breast Cancer PatientsПодробнее

Breast Cancer and HER2-Low: A Distinct Biology or an Artifact of Testing?Подробнее

HER2 Testing Explained: Procedure, Importance, and Treatment Options with Dr. Sudip HaldarПодробнее

Ask a Pathologist: Why Do I Need Another HER2 Test?Подробнее

iMetaOmics | Artificial intelligence for precision HER2-positive breast cancer managementПодробнее

HER2 Testing Strategies Across Tumor Types Amidst Guidelines GapsПодробнее

Diapath LabTalks: Evaluation of HER2 status in breast cancerПодробнее

HER2 Positive Breast Cancer Q&A: Symptoms, Treatment Options, and Progress | Dr Udip & Dr JayПодробнее

Revolutionizing HER2 Interpretation: AI Breakthrough Unveiled by Dr. Chaim Linhart (USCAP 2024)Подробнее

FISH: HER2 (ERBB2) AMPLIFICATIONПодробнее

Optimizing the Identification of HER2-Low Breast Cancer (Video Lecture)Подробнее

Assessing Risk in Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: How to Approach Ch...Подробнее

Addressing the Challenge of HER2 Heterogeneity in Breast CancerПодробнее

HER2 Testing for the Pathologist: Is Your Clinic Up to Date With the Latest Developments?Подробнее

Dr. Elena Provenzano Unveils the Future of AI in HER2 Low Interpretation at USCAP 2024Подробнее

Decoding HER2 in NSCLC: Advances in biomarker testing and targeted therapiesПодробнее